Skip to main content

Table 2

From: Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer

Characteristics   Total95 MICA highN=38 MICA lowN=57 p-value
Sex Male 66 25 41 0.524
  Female 29 13 16  
Age <65 67 21 46 0.008
  ≥65 28 17 11  
Histological grade G1-G2 48 23 25 0.111
  G3-G4 47 15 32  
Stage II 44 23 21 0.023
  III 51 15 36  
Adjuvant Chemotherapy Xelox, Folfox4 57 25 32 0.347
  PF 38 13 25  
CIK cycles <5 54 18 36 0.128
  ≥5 41 20 21